p53 and MDM2 immunostaining in pulmonary blastomas and bronchogenic carcinomas

Human Pathology

Volumn 27, Issue 6, 1996, Pages 542-546

  Pacinda, Susan J ^b   Ledet, Suzanne C ^b   Gondo, Margaret M ^b   Langston, Claire ^b   Brown, Richard W ^b   Carmona, Pedro A ^b   Franklin, Raymond B ^b   Roggli, Victor L ^b   Cagle, Philip T ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

immunohistochemistry; lung carcinoma; murine double minute 2; p53; pulmonary blastoma

Indexed keywords

GENE PRODUCT; MONOCLONAL ANTIBODY; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; LUNG BLASTOMA; LUNG CARCINOMA; MALE; PATHOGENESIS; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 0029992335     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90159-8     Document Type: Article

References (30)

1. Cohen M, Emms M, Kaschula ROC: Childhood pulmonary blastoma: A pleuropulmonary variant of the adult-type pulmonary blastoma. Pediatr Pathol 11:737-749, 1991
2. Peacock MJ, Whitwell F: Pulmonary blastoma. Thorax 31:197-204, 1976
3. Dehner LP: Pleuropulmonary blastoma is the pulmonary blastoma of childhood. Semin Diagn Pathol 11:144-151, 1994
4. Barnard WG: Embryoma of lung. Thorax 7:299-301, 1952
5. Spencer H: Pulmonary blastomas. J Pathol Bacteriol 82:161-165, 1961
6. Karin RL, Kirkham SE, Young RH, et al: Pulmonary blastoma with argyrophil cells and lacking sarcomatous features. Am J Surg Pathol 6:165-172, 1982
7. Kodama T, Shimosato Y, Watanabe S, et al: Six cases of well differentiated adenocarcinoma simulating fetal lung tubules in pseudoglandular stage: Comparison with pulmonary blastoma. Am J Surg Pathol 8:735-744, 1984
8. Berean K, Truong LD, Dudley AW, et al: Immunohistochemical characterization of pulmonary blastoma. Am J Clin Pathol 89:773-777, 1988
9. Heckman CJ, Truong LD, Cagle PT, et al: Pulmonary blastoma with rhabdomyosarcomatous differentiation: An electron microscopic and immunohistochemical study. Am J Surg Pathol 12:35-401, 1988
10. Nakatani Y, Dickersin GR, Mark EJ: Pulmonary endodermal tumor resembling fetal lung: A clinicopathologic study of five cases with immunohistochemical and ultrastructural characterization. HUM PATHOL 21:1097-1107, 1990
11. Yousem SA, Wick MR, Randhawa P, et al: Pulmonary blastoma: An immunohistochemical analysis with comparison with fetal lung in its pseudoglandular stage. Am J Clin Pathol 93:167-175, 1990
12. Koss MN, Hochholzer L, O'Leary T: Pulmonary blastomas. Cancer 67:2368-2381, 1991
13. Manivel JC, Priest JR, Watterson J, et al: Pleuropulmonary blastoma: The so-called pulmonary blastoma of childhood. Cancer 62:1516-1526, 1988
14. Hachitanda Y, Aoyama C, Sato JK, et al: Pleuropulmonary blastoma in childhood: A tumor of divergent differentiation. Am J Surg Pathol 17:382-391, 1993
15. Murphy JJ, Blair GK, Fraser GC, et al: Rhabdomyosarcoma arising within congenital pulmonary cysts: Report of three cases. J Pediatr Surg 27:1364-1367, 1992
16. Bauermeister DE, Jenning ER, Beland AH, et al: Pulmonary blastoma: A form of carcinosarcoma. Am J Clin Pathol 46:322-329, 1966
17. Davis PW, Briggs JC, Seal AME, et al: Benign and malignant mixed tumours of the lung. Thorax 27:657-673, 1972
18. Edwards CW, Saunders AM, Collins F: Mixed malignant tumor of the lung. Thorax 34:629-636, 1979
19. Dosaka-Akita H, Shindoh M, Fujino M, et al: Abnormal p53 expression in human lung cancer is associated with histologic subtypes and patient smoking history. Am J Clin Pathol 102:660-664, 1994
20. Leach FS, Tokino R, Meltzer P, et al: p53 Mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 53:2231-2234, 1993
21. Walker C, Robertson LJ, Myskow MW, et al: p53 Expression in normal and dysplastic bronchial epithelium and in lung carcinomas. Br J Cancer 70:297-303, 1994
22. Momand JG, Zambetti GP, Olson DC, et al: The MDM2 oncogene product forms a complex with the p53 protein and inhibits p53 mediated transactivation. Cell 69:1237-1245, 1992
23. Barak Y, Juven R, Haffner R, et al: MDM2 expression is induced by wild type p53 activity. EMBO J 12:461-468, 1993
24. Cagel PT, Brown RW, Lebovitz RM: p53 Immunostaining in the differentiation of reactive processes from malignancy in pleural biopsy specimens. HUM PATHOL 25:443-448, 1994
25. Bartek J, Bartkova J, Vojtesek B: Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 5:1297-1301, 1991
26. Hollstein M, Sidransky D, Vogelstein B, et al: p53 Mutations in human cancers. Science 253:49-53, 1991
27. Levine AJ, Momand J, Finlay CA: The p53 tumor suppressor gene. Nature 351:453-456, 1991
28. Iggo R, Gatter K, Bartek J: Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 335:675-679, 1990
29. Isobe M, Emanuel BS, Giovol D, et al: Localization of gene for human p53 tumor antigen to band 17p13. Nature 320:84-85, 1986
30. Waber PG, Chen J, Nisen P: Infrequency of MDM2 gene amplification in pediatric solid tumors and lack of association with p53 mutations in adult squamous cell carcinomas. Cancer Res 53:6028-6030, 1993